Anti-inflammatory agents may improve anti-depressant effects
Some anti-inflammatory drugs seem to improve antidepressant treatment effects and depression symptoms, according to a large evidence review in Acta Psychiatrica Scandinavica.
Data from 36 trials was included. Anti‐inflammatory agents (NSAIDs, cytokine inhibitors, statins, glucocorticoids and minocycline) improved depressive symptoms compared to placebo as add‐on in people with major depressive disorder and when taken alone.
In the trials that did report on adverse effects, researchers found no increased risks for gastrointestinal symptoms, pain/muscle aching or cardiovascular events in people on anti-inflammatory agents compared with those on placebo. But there was an increased risk for infections.
“Anti‐inflammatory agents improved antidepressant treatment effects,” the group concludes. “Future randomised clinical trials need to include longer follow‐up, identify optimal doses and subgroups of patients that can benefit from anti‐inflammatory intervention. This definitely bolsters our chances of being able to provide personalized treatment for individual patients in the longer term. Of course, we always have to weigh the effects against the potential side-effects of the anti-inflammatory drugs.”
Arthritis Digest Magazine was selected by Feedspot as one of the Top 5 Arthritis Blogs on the internet in 2018.
For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.